Part III. Review Questions

  1. Compare and contrast a phase II and phase III clinical trial.
  2. Define adulterated food.
  3. Discuss the role of the FDA in the regulation of dietary supplements.
  4. Define an IND (Investigational New Drug Application).
  5. What three parameters does the FDA examine when considering a NDA (New Drug Application)?

License

Icon for the Creative Commons Attribution-NonCommercial 4.0 International License

Drug and Nutrient Interactions Copyright © 2023 by Sara Police and Jesse Hoffman is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, except where otherwise noted.

Share This Book